dc.contributor.author | Magalona, Sophia | |
dc.contributor.author | Wood, Shannon N. | |
dc.contributor.author | Omoluabi, Elizabeth | |
dc.date.accessioned | 2022-08-05T09:26:20Z | |
dc.date.available | 2022-08-05T09:26:20Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Magalona, S. et al. (2022). DMPA-SC stock: Cross-site trends by facility type. Contraception: X, 4, 100075. https://doi.org/10.1016/j.conx.2022.100075 | en_US |
dc.identifier.issn | 0010-7824 | |
dc.identifier.uri | https://doi.org/10.1016/j.conx.2022.100075 | |
dc.identifier.uri | http://hdl.handle.net/10566/7707 | |
dc.description.abstract | To measure trends in the supply of DMPA-SC in public and private health facilities and com-
pare with other prominent modern methods.
Study design: We used repeated cross-sectional data from service-delivery-point surveys in six settings:
Burkina Faso, Democratic Republic of Congo (Kinshasa and Kongo Central), Nigeria (Kano and Lagos), and
Uganda, each with 3-5 rounds of data collected between 2016 and 2020. We analyzed trends in DMPA-SC
availability using percent of service delivery points offering the method and percent experiencing stock-
outs; trends were compared with those for DMPA-IM, IUD, implants, and other short-acting methods, by
facility type. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Family planning | en_US |
dc.subject | Reproductive health | en_US |
dc.subject | Contraception | en_US |
dc.subject | Population | en_US |
dc.subject | Sub-Saharan Africa | en_US |
dc.title | DMPA-SC stock: Cross-site trends by facility type | en_US |
dc.type | Article | en_US |